Thalidomide Maintenance Treatment in DLBCL

Clinical trial NCT03016000 · UNKNOWN

Trial details

NCT number: NCT03016000
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse

Start date: 2017-07-26
Primary completion: 2019-12-01
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.